rs969592968
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4BP6_ModerateBS2
The NM_001127222.2(CACNA1A):c.3178C>T(p.Pro1060Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000479 in 1,461,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 missense
NM_001127222.2 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 3.66
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1A. . Gene score misZ 5.7845 (greater than the threshold 3.09). Trascript score misZ 3.9354 (greater than threshold 3.09). GenCC has associacion of gene with benign paroxysmal torticollis of infancy, developmental and epileptic encephalopathy, 42, undetermined early-onset epileptic encephalopathy, episodic ataxia type 2, familial or sporadic hemiplegic migraine, spinocerebellar ataxia type 6, Lennox-Gastaut syndrome, migraine, familial hemiplegic, 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.39107397).
BP6
Variant 19-13286878-G-A is Benign according to our data. Variant chr19-13286878-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 476250.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.3178C>T | p.Pro1060Ser | missense_variant | 20/47 | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.3178C>T | p.Pro1060Ser | missense_variant | 20/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.3190C>T | p.Pro1064Ser | missense_variant | 20/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.3184C>T | p.Pro1062Ser | missense_variant | 20/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.3040C>T | p.Pro1014Ser | missense_variant | 19/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.3190C>T | p.Pro1064Ser | missense_variant | 20/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.3184C>T | p.Pro1062Ser | missense_variant | 20/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246176Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134248
GnomAD3 exomes
AF:
AC:
4
AN:
246176
Hom.:
AF XY:
AC XY:
1
AN XY:
134248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461356Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 726980
GnomAD4 exome
AF:
AC:
7
AN:
1461356
Hom.:
Cov.:
35
AF XY:
AC XY:
2
AN XY:
726980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;.;.;L;.;.;.;.;.;.;.;L;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Benign
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
MutPred
0.23
.;.;Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);.;.;Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);
MVP
MPC
0.085
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at